| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/30/1998 | WO1998017317A2 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates |
| 04/30/1998 | WO1998017316A1 Potent transdermal penetration enhancers |
| 04/30/1998 | WO1998017315A2 Permeation enhancers for transdermal drug delivery compositions, devices, and methods |
| 04/30/1998 | WO1998017310A2 Polyanionic polymers as adjuvants for mucosal immunization |
| 04/30/1998 | WO1998017285A1 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics |
| 04/30/1998 | WO1998017260A1 Chemo-mechanical expansion delivery system |
| 04/30/1998 | WO1998017253A1 Method and compositions for disrupting the epithelial barrier function |
| 04/30/1998 | WO1998017252A1 Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
| 04/30/1998 | WO1998017250A1 Pharmaceutical composition for rapid suspension in aqueous media |
| 04/30/1998 | WO1998017249A1 Ophthalmic compositions containing a carbonic anhydrase inhibitor and xanthan gum |
| 04/30/1998 | WO1998017242A1 Unique peptides for targeting fibronectin-enriched surfaces and a method for their delivery in the treatment of metastatic cancer |
| 04/30/1998 | WO1998011900A3 Compositions containing cobalamin and amino acids |
| 04/30/1998 | DE19746362A1 Production of nucleic acid conjugates |
| 04/30/1998 | CA2271721A1 Mini-e1a genes and gene products |
| 04/30/1998 | CA2269552A1 Ophthalmic compositions containing a carbonic anhydrase inhibitor and xanthan gum |
| 04/30/1998 | CA2269444A1 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates |
| 04/30/1998 | CA2268804A1 Composition containing chitosan |
| 04/30/1998 | CA2268476A1 Use of hyaluronan in gene therapy |
| 04/30/1998 | CA2268365A1 Il-12 gene expression and delivery systems and uses |
| 04/29/1998 | EP0838472A1 Peptides binding to low-density lipoproteins |
| 04/29/1998 | EP0838430A1 Fine particles of petaloid porous hydroxyapatite and process for producing the same |
| 04/29/1998 | EP0838225A2 Aqueous local anesthetic solution |
| 04/29/1998 | EP0838224A2 Polymer-drug conjugates with an enzyme cleavable linker |
| 04/29/1998 | EP0838221A1 Lyophilized hgf preparations |
| 04/29/1998 | EP0838218A1 Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance |
| 04/29/1998 | EP0837883A2 Method of solubilizing, purifying, and refolding protein |
| 04/29/1998 | EP0837882A1 Collagen peptide fraction and its uses |
| 04/29/1998 | EP0837862A1 Warming compounds |
| 04/29/1998 | EP0837699A1 Immunovectors for the intracellular and intranuclear transport |
| 04/29/1998 | EP0837698A1 Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates |
| 04/29/1998 | EP0837696A1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 04/29/1998 | EP0837690A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least one basic amino acid residue and at least one acid amino acid residue |
| 04/29/1998 | EP0837682A1 Therapeutic use of 1-amino-3-(n,n-dimethylamino)-propyliden-1,1-bisphosphonic acid and its salts |
| 04/29/1998 | EP0837673A2 Polymeric lamellar substrate particles for drug delivery |
| 04/29/1998 | EP0837672A1 Preparations and methods for the treatment of t cell mediated diseases |
| 04/29/1998 | EP0722340B1 Immunological tolerance-inducing agent |
| 04/29/1998 | EP0465529B1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 04/29/1998 | CN1180315A Pharmaceutical composition for parenteral application containing an indole-carboxylic acid |
| 04/29/1998 | CN1180310A Novel compositions of lipids and stabilizing materials |
| 04/29/1998 | CN1179979A Ophithalmic formulation for treating myopia comprising dopamine agonist and cyclodextrin |
| 04/29/1998 | CN1179942A Long-acting subcutaneous contraceptive implanting agent containing pregnadienone |
| 04/28/1998 | US5744625 Cationic transport reagents |
| 04/28/1998 | US5744592 Improving the bioavailability and absorption of a drug through the digestive tract by covalently bonding the drug and a 1-o-or-s-alkyl-sn-glycero-3-phosphate |
| 04/28/1998 | US5744580 Fusion protein |
| 04/28/1998 | US5744545 Biocompatible adhesive compositions |
| 04/28/1998 | US5744484 Lubeluzole intravenous solutions |
| 04/28/1998 | US5744329 DNA encoding fused di-beta globins and production of pseudotetrameric hemoglobin |
| 04/28/1998 | US5744302 Method for separating molecules |
| 04/28/1998 | US5744300 Screening to identify one or more test compounds that can alter gene expression in senescent cells |
| 04/28/1998 | US5744166 A complex of polycationic polymer and a drug in a carrier |
| 04/28/1998 | US5744165 Antiinflammatory agents, analgesics |
| 04/28/1998 | US5744164 Sustained release microparticulate caffeine formulation |
| 04/28/1998 | US5744163 Sustained release formulation of animal growth hormone and process for preparation thereof |
| 04/28/1998 | US5744162 Therapeutic plaster |
| 04/28/1998 | US5744161 Gastrointestinal absorption |
| 04/28/1998 | US5744153 Liquid delivery compositions |
| 04/28/1998 | US5744152 Polymeric compositions and methods of producing them |
| 04/28/1998 | US5744151 Silver-based pharmaceutical compositions |
| 04/28/1998 | US5744132 Formulations for IL-12 |
| 04/28/1998 | US5744125 Oxidative polymerization of precursors that enhance substantivity or adherence to hair or skin |
| 04/28/1998 | US5744124 Container having pump spray means for dispensing spray dosage into buccal area; propellant-free |
| 04/28/1998 | CA2102859C Expression vector for phytolacca antiviral protein |
| 04/28/1998 | CA2045358C Controlled release pharmaceutical preparation |
| 04/28/1998 | CA2044043C Process for the production of rapidly disintegrating sheet-like presentations |
| 04/25/1998 | CA2219439A1 Aqueous local anesthetic solution, method for improving solubility of local anesthetic, local anesthetic agent with decreased neurotoxicity and method for decreasing neurotoxicityof local anesthetic agent |
| 04/23/1998 | WO1998016918A1 Method for recovering data from disk with magneto-resistive head in presence of thermal asperities |
| 04/23/1998 | WO1998016255A2 Stabilized conjugates of uncomplexed subunits of multimeric proteins |
| 04/23/1998 | WO1998016254A1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/23/1998 | WO1998016253A1 Bioactive polymer product |
| 04/23/1998 | WO1998016252A1 New pharmaceutical parenteral formulation of a thrombin inhibitor |
| 04/23/1998 | WO1998016251A1 New carrier systems |
| 04/23/1998 | WO1998016250A1 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 04/23/1998 | WO1998016247A1 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/23/1998 | WO1998016246A1 Cytokine enhanced immunotherapy for brain tumors |
| 04/23/1998 | WO1998016240A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 04/23/1998 | WO1998016237A1 Anion exchange resin-containing tablets |
| 04/23/1998 | WO1998016229A1 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
| 04/23/1998 | WO1998016212A1 Local anesthetic for external use |
| 04/23/1998 | WO1998016209A2 Bioceramic compositions |
| 04/23/1998 | WO1998016208A1 Methods and apparatus for treatment of parkinson's disease |
| 04/23/1998 | WO1998016206A1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| 04/23/1998 | WO1998016204A1 Process for the manufacture of a pulverous preparation |
| 04/23/1998 | WO1998016203A1 Stabilized gas-supersaturated emulsions and suspensions |
| 04/23/1998 | WO1998016202A2 Fusogenic liposome composition and method |
| 04/23/1998 | WO1998016201A1 Therapeutic liposome composition and method |
| 04/23/1998 | WO1998016197A1 Surgical method and composition therefor |
| 04/23/1998 | WO1998016111A1 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 04/23/1998 | WO1998007429A3 Antifungal composition with enhanced bioavailability |
| 04/23/1998 | WO1997047323A3 Chitosan drug delivery system |
| 04/23/1998 | CA2505445A1 Fusogenic liposome composition and method |
| 04/23/1998 | CA2268809A1 Biologically active polymer products |
| 04/23/1998 | CA2268535A1 Local anesthetic for external use |
| 04/23/1998 | CA2268405A1 Stabilized gas-supersaturated emulsions and suspensions |
| 04/23/1998 | CA2267977A1 Cytokine enhanced immunotherapy for brain tumors |
| 04/23/1998 | CA2240402A1 Anion exchange resin-containing tablets |
| 04/22/1998 | EP0836647A2 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/22/1998 | EP0836645A1 Dry powder formulations of polynucleotide complexes |
| 04/22/1998 | EP0836511A1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 04/22/1998 | EP0836506A1 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| 04/22/1998 | EP0836483A2 Compositions in glassy phase, stabilised by a sugar |